ZAI Lab of Shanghai In-licenses Two Respiratory Drugs from Sanofi

ZAI Lab Limited, a novel drug development company located in Shanghai, broke out of stealth mode by announcing a major deal: the company has obtained global rights for two novel compounds from Sanofi, both of which are potential treatments for chronic respiratory diseases. ZAI is led by Dr. Samantha Du, who founded the company and serves as CEO. For ten years, Dr. Du was CEO of Hutchinson MediPharma, one of China’s very first innovative drug development companies. Since 2012, Dr. Du has been a Venture Partner of Sequoia Capital China. More details.... Stock Symbol: (NYSE: SNY) Share this with colleagues: // //